Wednesday, May 6, 2026
HomeTagsHealthcare

Healthcare

Hummingbird Bioscience Announces First Patient Dosed in Phase 1 Clinical Trial of HMBD-001 in Advanced HER3-Expressing Solid Malignancies

Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets in cancer and autoimmune disease, and Cancer Research UK,...

Werfen Announces CE Mark for Aptiva CTD Essential Reagent

Werfen, a worldwide leader in specialized diagnostics for autoimmune disease, is pleased to announce the CE Mark of Aptiva® CTD Essential Reagent for use...

AIkido Pharma Announces Strategic Interest in ASP Isotopes Inc.

AIkido Pharma Inc. announced that the Company secured a strategic equity interest in ASP Isotopes, Inc., which focuses on the non-nuclear supply of enriched...

Darling Ingredients’ Rousselot® Health Brand Obtains A Granted Patent from the European Patent Office for its SiMoGel™ Solution.

Rousselot, Darling Ingredients' health brand, and the global leader of collagen-based solutions1, announces that the European Patent Office (EPO) has granted the company's patent...

Kazia Announces Positive Final Data From Phase II Clinical Study Of Paxalisib In Newly Diagnosed Glioblastoma

Kazia Therapeutics Limited , an oncology-focused drug development company, is pleased to announce positive final data from a phase II clinical study of paxalisib...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics